Clinical and demographic factors affecting trough levels of isavuconazole in critically ill patients with or without COVID-19.
Bertram R, Naumann HT, Bartsch V, Hitzl W, Kinzig M, Haarmeyer GS, Baumgärtel M, Geise A, Muschner D, Nentwich J, John S, Sörgel F, Steinmann J, Höhl R.
Bertram R, et al. Among authors: bartsch v.
Mycoses. 2023 Dec;66(12):1071-1078. doi: 10.1111/myc.13653. Epub 2023 Sep 12.
Mycoses. 2023.
PMID: 37700457